ClinicalTrials.Veeva

Menu

Senyo Health With Substance Use Disorder (SUD) in Primary Care

Mayo Clinic logo

Mayo Clinic

Status

Invitation-only

Conditions

Substance Use Disorders
Substance Abuse

Treatments

Behavioral: Follow-up
Behavioral: Senyo App

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT06743282
24-007758
1R18HS029774-01 (U.S. AHRQ Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to examine the barriers, facilitators, and optimal processes for implementing a digitally enhanced screening, brief intervention, and referral to treatment (SBIRT) model for Substance Use Disorder SUD treatment among Mayo primary care clinics.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability to read, write, and understand English
  • Minimum DAST (1+), audit-C score (3+)
  • Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care.
  • Access to or willingness to obtain a Primary care provider at a participating Mayo Clinic site;
  • Eligibility determined by ASAM Assessment

Exclusion criteria

  • Diagnosed personality pathology as the primary presenting concern based on clinical judgment, severe cognitive impairment (e.g., intellectual disability or dementia), or psychosis
  • Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment
  • Needing a higher level of mental health care as demonstrated by ASAM32 assessment.
  • Decline to answer suicidality questions.
  • Already admitted into or about to initiate treatment in another addiction treatment program.

Currently attending High School.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Senyo
Experimental group
Description:
Subjects to the Senyo group will begin receiving intervention immediately, and will move to the follow-up phase after 12 weeks.
Treatment:
Behavioral: Senyo App
Behavioral: Follow-up

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems